Stephen Aylward
See the following -
Dr. Stephen Aylward Elected To MICCAI Board Of Directors
On Friday, October 19th, Dr. Stephen Aylward, Kitware’s Senior Director of Operations in North Carolina, was elected to the MICCAI Society’s Board of Directors. Dr. Aylward was appointed to this position along with Josien Pluim of the Image Sciences Institute after a competitive vote, which was validated, reviewed, and ratified by the current Board of Directors. Read More »
- Login to post comments
Kitware Makes a Positive Impact at 2012 MICCAI Conference
Dr. Stephen Aylward elected to Board of Directors, Roland Kwitt awarded Young Scientist Award, and Kitware sponsors Young Scientist Publication Impact Award. Read More »
- Login to post comments
Kitware to Develop Novel Neuroimage Processing Methods for Traumatic Brain Injury
The NIH-funded project will investigate new methods for better assessing Traumatic Brain Injury.
Read More »
- Login to post comments
Kitware to Develop Quantitative Cancer Assessment Environment
Kitware, a leading-edge software R&D and consulting provider, today announces the award of $298,436 in Phase I SBIR funding from the National Institutes of Health. The funding will be used to develop an ultrasound-based quantitative diagnostic approach for assessing tumor malignancy and predicting tumor outcomes. Read More »
- Login to post comments
NIH Awards $1.26 Million to Kitware and Collaborators for Cancer Treatment Research: Are Microvessels Early Indicators of Cancer Treatment Efficacy?
The research project is centered on a novel approach to cancer detection and diagnosis that is based on using acoustic angiography to measure small changes in the microvessels that feed tumors. Acoustic angiography is a contrast-enhanced ultrasound imaging technique that is being developed by Dr. Paul Dayton at The University of North Carolina at Chapel Hill (UNC), who is a principal investigator on the project. The technique can provide unprecedented clarity in visualizing microvascular abnormalities associated with malignant cancers that resolve when those cancers respond to treatment.
- Login to post comments